193 related articles for article (PubMed ID: 38343536)
1. Constructing models for Crohn's disease diagnosis and prediction of infliximab non-response based on angiogenesis-related genes.
Zheng C; Chen X; Ke Y; Xu X; Wu C; Jiang L
Front Immunol; 2024; 15():1239496. PubMed ID: 38343536
[TBL] [Abstract][Full Text] [Related]
2. FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization.
Ye C; Zhu S; Yuan J; Yuan X
J Inflamm Res; 2024; 17():3949-3966. PubMed ID: 38911989
[TBL] [Abstract][Full Text] [Related]
3. Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn's disease.
Xu Y; Wang S; Ye Z; Zhang H
Front Immunol; 2024; 15():1401733. PubMed ID: 38840917
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn's disease.
Wang J; Li Z; Xiao J; Wu L; Chen K; Zhu T; Feng C; Zhuansun D; Meng X; Feng J
Front Immunol; 2022; 13():961217. PubMed ID: 36248794
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of key long non-coding RNAs using co-expression network analysis in Crohn's disease.
Rui Q; Lu C; Song S; Zhang L
Ann Palliat Med; 2021 Sep; 10(9):9627-9639. PubMed ID: 34628888
[TBL] [Abstract][Full Text] [Related]
6. A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
Billiet T; Papamichael K; de Bruyn M; Verstockt B; Cleynen I; Princen F; Singh S; Ferrante M; Van Assche G; Vermeire S
J Crohns Colitis; 2015 Dec; 9(12):1120-6. PubMed ID: 26351386
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn's Disease.
Ye C; Zhu S; Yuan J
Front Immunol; 2022; 13():871312. PubMed ID: 35529850
[TBL] [Abstract][Full Text] [Related]
8. Identification of platelet-related subtypes and diagnostic markers in pediatric Crohn's disease based on WGCNA and machine learning.
Tang D; Huang Y; Che Y; Yang C; Pu B; Liu S; Li H
Front Immunol; 2024; 15():1323418. PubMed ID: 38420127
[TBL] [Abstract][Full Text] [Related]
9. Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors.
Hlavaty T; Ferrante M; Henckaerts L; Pierik M; Rutgeerts P; Vermeire S
Inflamm Bowel Dis; 2007 Apr; 13(4):372-9. PubMed ID: 17206723
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA Antisense Noncoding RNA in the INK4 Locus Correlates With Risk, Severity, Inflammation and Infliximab Efficacy in Crohn's Disease.
Ge Q; Dong Y; Lin G; Cao Y
Am J Med Sci; 2019 Feb; 357(2):134-142. PubMed ID: 30665494
[TBL] [Abstract][Full Text] [Related]
11. Characterization of PANoptosis-related genes in Crohn's disease by integrated bioinformatics, machine learning and experiments.
Yang Y; Hounye AH; Chen Y; Liu Z; Shi G; Xiao Y
Sci Rep; 2024 May; 14(1):11731. PubMed ID: 38778086
[TBL] [Abstract][Full Text] [Related]
12. Bioelectrical impedance analysis-based nomogram construction for predicting secondary loss of response to infliximab in bio-naïve Crohn's disease patients.
Yueying C; Jing F; Tian Y; Yuqi Q; Jun S
Biomed Pharmacother; 2021 Oct; 142():112076. PubMed ID: 34449314
[TBL] [Abstract][Full Text] [Related]
13. Infliximab response associates with radiologic findings in bio-naïve Crohn's disease.
Yueying C; Jing F; Qi F; Jun S
Eur Radiol; 2023 Aug; 33(8):5247-5257. PubMed ID: 36928565
[TBL] [Abstract][Full Text] [Related]
14. A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn's Disease.
Li L; Chen R; Zhang Y; Zhou G; Chen B; Zeng Z; Chen M; Zhang S
Front Immunol; 2021; 12():646673. PubMed ID: 34367126
[TBL] [Abstract][Full Text] [Related]
15. Intestinal ultrasound score predicts therapeutic outcomes of infliximab in pediatric patients with Crohn's disease.
Wang L; Zhang Y; Wu H; Tang Z; Wang Y; Huang Y
Scand J Gastroenterol; 2024; 59(2):156-163. PubMed ID: 37905747
[TBL] [Abstract][Full Text] [Related]
16. Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naïve Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes.
Ashton JJ; Boukas K; Davies J; Stafford IS; Vallejo AF; Haggarty R; Coelho TAF; Batra A; Afzal NA; Vadgama B; Williams AP; Beattie RM; Polak ME; Ennis S
J Crohns Colitis; 2021 May; 15(5):774-786. PubMed ID: 33232439
[TBL] [Abstract][Full Text] [Related]
17. CT enterography-based radiomics combined with body composition to predict infliximab treatment failure in Crohn's disease.
Song F; Ma M; Zeng S; Shao F; Huang W; Feng Z; Rong P
Radiol Med; 2024 Feb; 129(2):175-187. PubMed ID: 37982937
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil Infiltration Characterized by Upregulation of S100A8, S100A9, S100A12 and CXCR2 Is Associated With the Co-Occurrence of Crohn's Disease and Peripheral Artery Disease.
Yao Z; Zhang B; Niu G; Yan Z; Tong X; Zou Y; Li Y; Yang M
Front Immunol; 2022; 13():896645. PubMed ID: 35795659
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
Yuan Y; Fu M; Li N; Ye M
Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
[TBL] [Abstract][Full Text] [Related]
20. Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods.
Chen ZA; Ma HH; Wang Y; Tian H; Mi JW; Yao DM; Yang CJ
Sci Rep; 2023 Feb; 13(1):2694. PubMed ID: 36792688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
